Abstract
Genes involved in the hemostatic mechanism are logical candidate genes for association studies in prothrombotic conditions such as stroke. Since the underlying etiology in pediatric strokes is different than adults, looking for genetic causes would be the logical thing to do in the pediatric stroke population. Fifty-eight Asian-Indian stroke patients below 15 years of age and equal number of age- and sex-matched healthy controls were the subjects for the study. The subjects were screened for 13 polymorphisms and three mutations spread across seven different candidate genes involved in the hemostatic system. Of the 13 polymorphisms and three mutations studied, four polymorphisms, HPA-I, TAFI 147Ala>Thr, methylene tetrahydrofolate reductase (MTHFR) 677 C>T, and MTHFR 1298 A>C, showed significant association with the disease phenotype. MTHFR 677 C>T showed the strongest association and therefore may have a strong predisposing role for pediatric strokes. Gene–gene interaction studies showed a strong interaction between HPA-I and MTHFR 677 C>T polymorphism. The wild type of both these polymorphisms synergistically showed a strong protective effect [p < 0.0001, O.R: 10.06(4.26–23.71)]. Polymorphisms in HPA-I and MTHFR may have important predisposing roles in the development of pediatric stroke.
Similar content being viewed by others
References
Broderick J, Talbot GT, Prenger E, Leach A, Brott T (1993) Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 8:250–255
Schoenberg BS, Mellinger JF, Schoenberg DG (1978) Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology 28:763–768
Smith CD, Baumann RJ (1991) Clinical features and magnetic resonance imaging in congenital and childhood stroke. J Child Neurol 6:263–272
Salih MA, Murshid WR, Zahraa JN, Abdel-Gader AG, Al-Jarallah AA, Kentab AY et al (2006) Congenital and genetic cerebrovascular anomalies as risk factors for stroke in Saudi children. Saudi Med J 27(Suppl 1):S53–S60
Johal SC, Garg BP, Heiny ME, Williams LS, Saha C, Walsh LE et al (2006) Family history is a poor screen for prothrombotic genes in children with stroke. J Pediatr 148:68–71 doi:10.1016/j.jpeds.2005.08.032
Barreirinho S, Ferro A, Santos M, Costa E, Pinto-Basto J, Sousa A et al (2003) Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol 28:134–138 doi:10.1016/S0887-8994(02)00506-4
Millikan CH, Mc Dowell F, Easton JD (1987) Stroke in children. In: Stroke Philadelphia, Lee and Febgier:247–252
Henry M, Aubert H, Morange PE, Nanni I, Alessi MC, Tiret L et al (2001) Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. Blood 97:2053–2058 doi:10.1182/blood.V97.7.2053
Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S et al (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129:1656–1661
Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ et al (1998) Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke prevention in young women study. Stroke 29:581–585
Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M et al (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108:989–995 doi:10.1161/01.CIR.0000085073.69189.88
van’t Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A (1999) Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 19:3063–3070
Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R et al (1997) The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 17:2880–2884
Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR (1994) High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 88:219–222 doi:10.1111/j.1365-2141.1994.tb05005.x
Komlosi K, Havasi V, Bene J, Ghosh M, Szolnoki Z, Melegh G et al (2003) Search for factor V Arg306 Cambridge and Hong Kong mutations in mixed Hungarian population samples. Acta Haematol 110:220–222 doi:10.1159/000074233
Jadaon MM, Dashti AA (2005) HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait. J Thromb Haemost 3:1467–1471 doi:10.1111/j.1538-7836.2005.01326.x
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703
Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Bene J, Havasi V et al (2003) Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology. Thromb Res 109:265–269 doi:10.1016/S0049-3848(03)00258-5
Slowik A, Dziedzic T, Turaj W, Pera J, Glodzik-Sobanska L, Szermer P et al (2004) A2 alelle of GpIIIa gene is a risk factor for stroke caused by large-vessel disease in males. Stroke 35:1589–1593 doi:10.1161/01.STR.0000132194.24663.3d
Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C (1997) Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 28:1392–1395
Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K (1997) PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349:385–388 doi:10.1016/S0140-6736(97)80010-4
Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L et al (2000) Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 101:1013–1018
Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965–967 doi:10.1046/j.1365-2141.2000.02267.x
Undas A, Brummel K, Musial J, Mann KG, Szczeklik A (2001) Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104:2666–2672 doi:10.1161/hc4701.099787
Feng D, Lindpaintner K, Larson MG, Rao VS, O’Donnell CJ, Lipinska I et al (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham offspring study. Arterioscler Thromb Vasc Biol 19:1142–1147
Ilhan N, Kucuksu M, Kaman D, Ozbay Y (2008) The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 39:125–130 doi:10.1016/j.arcmed.2007.07.009
Kumar J, Das SK, Sharma P, Karthikeyan G, Ramakrishnan L, Sengupta S (2005) Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 50:655–663 doi:10.1007/s10038-005-0313-1
Akar N, Akar E, Ozel D, Deda G, Sipahi T (2001) Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 102:115–120 doi:10.1016/S0049-3848(01)00226-2
Rook JL, Nugent DJ, Young G (2005) Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations. J Pediatr Hematol Oncol 27:590–593 doi:10.1097/01.mph.0000188119.33452.fd
Haywood S, Liesner R, Pindora S, Ganesan V (2005) Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child 90:402–405 doi:10.1136/adc.2004.049163
Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M et al (2000) Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106:483–491 doi:10.1172/JCI8342
Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K et al (2002) Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106:2854–2858 doi:10.1161/01.CIR.0000039327.11661.16
Panigrahi I, Chatterjee T, Biswas A, Behari M, Choudhry PV, Saxena R (2006) Role of MTHFR C677T polymorphism in ischemic stroke. Neurol India 54:48–50, discussion 51–42
Kalita J, Srivastava R, Bansal V, Agarwal S, Misra UK (2006) Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients. Neurol India 54:260–263
Duran R, Biner B, Demir M, Celtik C, Karasalihoglu S (2005) Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 11:83–88 doi:10.1177/107602960501100110
Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Mardaraz C et al (2003) Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 73:81–86 doi:10.1002/ajh.10326
Ganesan V, McShane MA, Liesner R, Cookson J, Hann I, Kirkham FJ (1998) Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry 65:508–511
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Biswas, A., Tiwari, A.K., Ranjan, R. et al. Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients. Ann Hematol 88, 473–478 (2009). https://doi.org/10.1007/s00277-008-0613-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0613-6